Did any of you hear about this?
"The approach used by EpiVax is called Antigen-Specific Adaptive Tolerance Induction (ASATI) to specifically target and reduce undesirable immune responses. EpiVax used its proprietary computer algorithms to identify the molecules that induce ASATI. Because ASATI uses the body's own natural responses, this intervention has the potential to be far safer than immunosuppressive drugs that are now being studied. The promising treatment, called Epi-13, may have application to a broad range of auto-immune disorders.
EpiVax is pioneering the use of immunoinformatics for making safer, more effective human therapeutics. This approach also offers hope for individualizing therapies, also known as immuno-pharmacogenomics.
(READ MORE)


Diabetic Recipes












